Resident alveolar macrophages are highly susceptible to the induction of RIPK1/RIPK3-mediated necroptosis which promote efficient pulmonary immune response
Open Access
- 22 December 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1)
Abstract
Alveolar macrophages (AMs) play a crucial role in protecting the lungs from pathogens by inducing immunogenic cell death (ICD). However, the type of cell death that effectively induces protective immunity remains to be fully understood. In our investigation of the mechanisms regulating AM activation and lung immune responses, we found that AMs are highly susceptible to necroptosis, a form of ICD. Treatment with pan-caspase inhibitors, such as emricasan or benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethyl ketone (ZVAD-fmk), directly induced cell death in AMs, resulting in the release of interleukin (IL)-1α in the lungs. This phenomenon was not observed in mouse lung fibroblasts or bone marrow-derived macrophages, indicating a cell type-specific sensitivity. The process was mediated by receptor-interacting protein kinase (RIPK)1 and RIPK3, and notably occurred without any additional necroptosis triggers such as tumor necrosis factor (TNF) or second mitochondria-derived activator of caspase (SMAC) mimetics. Moreover, activation of the RIPK1–RIPK3 signaling pathway not only triggered necroptosis but also promoted IL-1α production and release. These responses were absent in AMs lacking functional RIPK1 kinase activity or deficient in RIPK3. Importantly, RIPK1/RIPK3-mediated cell death and IL-1α release were sufficient to trigger lung immune responses, as shown by increased antigen-specific IgG and IgA production, which was significantly decreased in mice deficient in necroptosis or lacking the IL-1 receptor. Taken together, these findings demonstrate that the pan-caspase inhibitor emricasan induces necroptotic cell death in AMs and may act as a promising AM-targeted adjuvant to enhance lung-specific acquired immunity.Keywords
This publication has 56 references indexed in Scilit:
- Influenza Virus Z-RNAs Induce ZBP1-Mediated NecroptosisCell, 2020
- Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With PlaceboClinical Gastroenterology and Hepatology, 2019
- Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1α Release to Promote Inducible Bronchus-Associated Lymphoid Tissue FormationImmunity, 2016
- Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological RelevanceImmunity, 2013
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- The use of a mutant TNF-α as a vaccine adjuvant for the induction of mucosal immune responsesBiomaterials, 2009
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-αCell, 2009
- TNF-α Induces Two Distinct Caspase-8 Activation PathwaysCell, 2008
- Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytesEuropean Journal of Immunology, 2002
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984